September 2023 FDA Biotech Catalysts – CNA Finance
CNA Finance is tracking 9 biotech companies with FDA catalysts coming in September. Those companies include Merck & Co (NYSE: MRK), BioLine Rx (Nasdaq: BLRX), Alnylam Pharmaceuticals (Nasdaq: ALNY), Halozyme Therapeutics (Nasdaq: HALO), ARS Pharmaceuticals (Nasdaq: SPRY), AnaptysBio (Nasdaq: ANAB), Appili Therapeutics (TSE: APLI), Citius Pharmaceuticals (NASDAQ: CTXR), Ocuphire Pharma (Nasdaq: OCUP). Read on to […]